Metraipolis › archive › dc_bfd5d073ca3f

Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis — Europe PMC PMID:41356193

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41356193
DOI
10.7150/thno.116749
License (as archived)
solo-consultazione
Archived
2026-11-07T04:40:27.047Z
SHA-256 of the archived text
35680f621946d0cb6d441d3402cdba5b7aadf1dd0884c03459f7b577e17a2127
Stable URL of this page
https://metraipolis.com/documento/dc_bfd5d073ca3f

How to cite

Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis — Europe PMC PMID:41356193 — Europe PMC (en), https://europepmc.org/article/MED/41356193 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfd5d073ca3f (Metraipolis archive dc_bfd5d073ca3f, sha256 35680f621946d0cb6d441d3402cdba5b7aadf1dd0884c03459f7b577e17a2127)
BibTeX
@misc{dcbfd5d073ca3f,
  title = {Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis — Europe PMC PMID:41356193},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41356193},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfd5d073ca3f; sha256 35680f621946d0cb6d441d3402cdba5b7aadf1dd0884c03459f7b577e17a2127},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41356193. Agents can read the archived copy with the MCP tool read_document.